Nuveen Asset Management, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2024$2,850,727
-74.2%
416,773
-65.7%
0.00%
-66.7%
Q1 2024$11,042,350
+144.5%
1,213,445
+19.8%
0.00%
+200.0%
Q4 2023$4,515,942
+42.2%
1,012,543
+0.1%
0.00%0.0%
Q3 2023$3,174,659
-33.1%
1,011,038
+9.9%
0.00%
-50.0%
Q2 2023$4,745,146
+466482.7%
919,602
+376.4%
0.00%
Q1 2023$1,017
+71.2%
193,033
-8.6%
0.00%
Q4 2022$594
-99.9%
211,160
-17.9%
0.00%
Q3 2022$1,068,000
-23.7%
257,262
-26.1%
0.00%
-100.0%
Q2 2022$1,399,000
-16.3%
348,097
+6.2%
0.00%0.0%
Q1 2022$1,672,000
-31.0%
327,819
-15.8%
0.00%0.0%
Q4 2021$2,423,000
-30.1%
389,548
+18.6%
0.00%0.0%
Q3 2021$3,466,000
-6.2%
328,520
+26.0%
0.00%0.0%
Q2 2021$3,697,000
-11.6%
260,708
+2.3%
0.00%0.0%
Q1 2021$4,184,000
-66.4%
254,951
-57.6%
0.00%
-75.0%
Q4 2020$12,434,000
+562.1%
600,671
+143.5%
0.00%
+300.0%
Q3 2020$1,878,000
+3.3%
246,722
+13.1%
0.00%0.0%
Q2 2020$1,818,000
+159.3%
218,234
+54.0%
0.00%
Q1 2020$701,000
+33.0%
141,749
+6.2%
0.00%
Q4 2019$527,000
-9.6%
133,488
-30.4%
0.00%
Q3 2019$583,000
+4.9%
191,831
+51.9%
0.00%
Q2 2019$556,000126,2900.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,784,850$15,064,00062.56%
Versant Venture Management, LLC 2,215,384$8,817,228,0004.36%
SV Health Investors, LLC 628,236$2,500,0001.54%
DELTEC ASSET MANAGEMENT LLC 724,747$2,885,0000.80%
Endurant Capital Management LP 232,727$926,0000.49%
NOTTINGHAM ADVISORS, INC. 146,946$1,011,0000.15%
JGP Global Gestao de Recursos Ltda. 12,568$50,0000.06%
Man Group plc 1,187,508$4,726,0000.02%
Dynamic Technology Lab Private Ltd 21,077$84,0000.02%
NewEdge Advisors, LLC 36,250$144,0000.01%
View complete list of OCULAR THERAPEUTIX INC shareholders